Getting Research Published

PUBLICATION STRATEGY – AN OVERVIEW

Step-by-Step Guide to Publication Strategy

Developing a Publication Plan for a Multicentre Study

How Long Will it Take?

Working with a Medical Writer

Dr. Seymour and the Disappearing Paper: A Cautionary Tale

A TO Z OF PUBLICATION STRATEGY

A
Abstracts
Acceptance rates
Acceptance times
Access to data
Accountability of authors
Acknowledgements
Advertising departments
Affiliations
American Medical Writers Association (AMWA)
Anonymous reviewers
Appeals
Approval
Article formats
Article processing charge (APC)
Artwork
Authors’ affiliations
Authorship

B
Back-up plan
Beall’s list
Bias
Bibliographic software
‘Big Five’
BioMed Central
Blinded (masked) review
Blogs
Board of Editors in the Life Sciences (BELS)
Books
Brief
By-line (or masthead)

C
Certified Medical Publication Professional (CMPP)
Checklists
ClinicalTrials.gov
Cloned journals
Co-authors
Collaborators
Committee on Publication Ethics (COPE)
Competing interest
Conditional acceptance
Conflict of interest / competing interest
Congress / conference choice
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)
CONSORT
CONSORT for Abstracts
Contact details
Contracts
Contributorship (vs. authorship)
COPE
Copy editing
Copyright
Corporate integrity agreement (CIA)
Corrections (errata)
Corresponding author
Council of Science Editors (CSE)
Cover letter / covering letter
Creative Commons (CC) licences
CrossCheck
CrossMark

D
Data access
Data analysis plan
Data dredging
Data ownership
DataVision
Deadlines
Decision times
DeepDyve
Diamond Open Access
Directory of Open Access Journals (DOAJ)
DOI (Digital Object Identifier) system
Duplicate publication

E
Economic (health outcomes) evaluations
Editorial board
Editorials
Editors
Electronic publishing
Electronic review
Electronic submission
ELPS
Embargoes
Encore abstracts
Enhanced publications
Envision
e- Prints
epub
EQUATOR Network
Errata
European Association of Science Editors (EASE)
European Clinical Trials Database (EudraCT)
European Federation of Pharmaceutical Industry Associations (EFPIA)
European Medical Writers Association (EMWA)
Expectations
Expedited review
External review

F
F1000Research
Fast-track publication
FDAAA
Fees
Figure legends
Figures
First author
Footnotes
Formatting requirements
Freebies / ‘throwaways’

G
Galley proofs
Gap analysis
Ghost authors
Ghost writers
Gift authorship
Gold Open Access
Good Publication Practice (GPP, GPP2 and GPP3)
Graphs
Green Open Access
Group authorship
Guarantor
Guest authors / gift authorship

H
Hanging Committee
Hijacked journals
Hot topics
House style
Hybrid journals

I
Image manipulation
Impact factors
IMRAD structure
Indexing
Informal review
Ingelfinger rule
In-house review
Initials
In press
Institutional repositories
Instructions to authors (contributors)
Internal review
International Clinical Trials Registry Platform (ICTRP)
International Committee of Medical Journal Editors (ICMJE)
International Society for Medical Publication Professionals (ISMPP)
Investigators’ agreements
ISRCTN (International Standard Randomised Controlled Trial Number)

J
Journal cascades and consortia
Journal choice
Journalists
JULIET

K
Key message(s)
Key people / players
Key words

L
Last author
Late breaker abstracts
Lead time
Legends
Letters to the editor

M
Masked review
Meat extenders
Media relations
Medical writers
Medline
Meeting choice
Meetings (of the writing group)
Mega-journal
MeSH headings
Metrics

N
Names
Negative studies
Nitpickers
Number of authors
Number of publications

O
Offprints
Ombudsman / ombudsperson
Open Access journals
Open Access Scholarly Publishers Association (OASPA)
OpenDOAR (the Directory of Open Access Repositories)
Open peer review
Oral presentations
ORCID (Open Researcher and Contributor ID)
Order of authors
Organisations
Outlines
Overlapping publications
Ownership of data

P
Page budget
Page charges
PeerJ
Peers
Permissions
Personal communications
Personal websites
Pharmaceutical Research and Manufacturers of America (PhRMA)
Physician Payments Sunshine Act
Pico / PICO
Placeholder abstracts
Plagiarism
Planning
Platinum Open Access
Pooled data
PLOS
Poster presentations
Post-publication comments
Post-publication peer review
Predatory journals
Predatory publishers
Preprints
Press conferences
Press releases
Pre- submission enquiries
Primary publication
Prior publication
PRISMA
Promoting your work
Proofs (page proofs)
Protocol review
Publication agreements
Publication bias
Publication Plan
Publication policy
Publication steering committee
Publication strategy
Public Library of Science (PLOS)
PubMed
PubMed Central
PubStrat

Q
Queries
Queues

R
Readership
Redundant publication
References
Reformatting
Rejection
Reporting guidelines
Reprints
Retractions
Reviewer choice
Reviewers’ comments
Review process
Role of sponsor
RoMEO
Running title

S
Salami science / slicing
Secondary publications
Second target journal
Selective publication
Self- archiving
SHERPA/FACT
SHERPA/JULIET
SHERPA/RoMEO
Short reports
Short title
Slides
Social media
Sponsor, role of
Strategy
STROBE
Style
Sub-editing
Submission fees
Submission letter
Subscription journals
Sunshine Act
Supplementary material
Supplements

T
Tables
Target audience
Target journal
Technical editing
Text recycling
The Publication Plan
‘Throwaways’
Timing
Title
Title page
Translations
Trial identifier
Trial registration

U
Editors (ICMJE)
Unpublished data (references to)

V
Vancouver Group
Verbal branding
Veto
Vicious reviewers

W
Waivers
WAME
Web publication / institutional websites
Withdrawal
World Association of Medical Editors (WAME)
World Medical Association (WMA)
Writing
Writing group

X
Xenophobia (geographical bias)

Y
Young reviewers

Z
Zealots and assassins

Appendix 1 Further reading

Appendix 2 Organisations

Appendix 3 Guidelines

Appendix 4 Principles of good publication practice for company sponsored medical research (from GPP3)